# Synthesis of sulfanyl derivatives of 1,2,4-triazoles via an acid catalyzed intramolecular cyclization of isothiosemicarbazones: structural characterization, E/Z isomerism, mechanistic insights and in vitro cytotoxicity

**Authors:** Kallivalappil Snisha, Mano Chitra Karthikeyan, Nattamai Bhuvanesh, Antony Joseph Velanganni Arockiam, Ramasamy Karvembu

PMC · DOI: 10.1039/d6ra00822d · 2026-03-10

## TL;DR

Researchers synthesized new 1,2,4-triazole compounds and found they are more effective at killing cancer cells than a common drug, with low toxicity to normal cells.

## Contribution

A novel acid-catalyzed method to synthesize sulfanyl 1,2,4-triazoles with enhanced cytotoxicity against cancer cells.

## Key findings

- Cyclized sulfanyl 1,2,4-triazoles showed higher cytotoxicity toward MDA-MB-231 and HeLa cells than 5-FU.
- Substituted compounds CL2 and CL3 exhibited enhanced activity compared to the unsubstituted CL1.
- Compounds induced apoptosis via ROS generation and mitochondrial membrane potential depletion.

## Abstract

Sulfanyl derivatives of 1,2,4-triazoles (CL1–CL3) were synthesized via a Lewis or Brønsted acid catalyzed intramolecular cyclization of corresponding isothiosemicarbazones (TL1–TL3). All the synthesized isothiosemicarbazones and their cyclized sulfanyl 1,2,4-triazole derivatives were well characterized by spectroscopic techniques and single crystal XRD analyses. The E/Z isomerism of the isothiosemicarbazones was elucidated using NMR spectroscopy and single crystal XRD analysis. Mechanistic investigations, supported by controlled experiments and spectroscopic evidence, revealed that the cyclization proceeded via an ionic pathway with the evolution of hydrogen. The cytotoxic effect of the cyclized sulfanyl 1,2,4-triazole derivatives (CL1–CL3) was evaluated by MTT assay against MDA-MB-231 (breast), MCF-7 (breast), and HeLa (cervical) cancer cell lines, as well as HEK-293 (kidney) normal cell line, taking 5-fluorouracil (5-FU) as a reference drug. All the substituted sulfanyl-1,2,4-triazoles showed higher cytotoxicity toward MDA-MB-231 and HeLa cells than 5-FU, while exhibiting low toxicity toward HEK-293 cells, indicating good selectivity toward cancer cells. Substituted compounds [CL2 (p-OCH3) and CL3 (p-NO2)] displayed enhanced activity compared to the unsubstituted one (CL1), indicating the influence of the substituents on cytotoxicity. Fluorescence staining assays (AO/EB, Hoechst 33342, Rhodamine 123 and DCFH-DA) further supported the observed cytotoxic effects, and suggested that the compounds promoted apoptotic cell death via intracellular reactive oxygen species (ROS) generation, depletion of mitochondrial membrane potential (MMP) and damage to nuclear material.

Sulfanyl derivatives of 1,2,4-triazoles were synthesized via a Lewis or Brønsted acid catalyzed intramolecular cyclization of isothiosemicarbazones, and their cytotoxicity was evaluated.

## Linked entities

- **Chemicals:** 5-fluorouracil (PubChem CID 3385), 5-FU (PubChem CID 3385)
- **Diseases:** breast cancer (MONDO:0004989), cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** cytotoxic (MESH:D064420), cervical (MESH:D002575), cancer (MESH:D009369)
- **Chemicals:** ROS (MESH:D017382), hydrogen (MESH:D006859), CL2 (MESH:D002713), 1,2,4-triazoles (MESH:C045575), Hoechst 33342 (MESH:C017807), MTT (MESH:C070243), Bronsted acid (-), Rhodamine 123 (MESH:D020112), DCFH-DA (MESH:C029569), 5-FU (MESH:D005472)

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12973506/full.md

---
Source: https://tomesphere.com/paper/PMC12973506